Jason Zoeller's work is publisehd in Breast Cancer Resesarch, evaluating the efficacy of combined therapy agents, Navitoclax and EGFR-ADC, in pre-clinical models of triple-negative breast cancer. Congrats Jason!
Department of Cell Biology
December 2020
Copyright © The President and Fellows of Harvard College